About Genomma Lab
Genomma Lab is a publicly listed company based in Mexico City (Mexico) founded in 1996 by Rodrigo Herrera Aspra. OTC and generic drugs are manufactured and distributed. The company has 1,600 employees. Genomma Lab has completed 2 acquisitions, including Bufferin and Prestige Brands. Its chief executive, as recorded, is Jorge Luis Brake Valderrama. Its website genommalab.com draws about 39 thousand monthly visits. Genomma Lab offers products and services including Medications and Personal Care Items. Its focus areas include Traditional Pharmaceuticals and Diversified. Its legal entity is Genomma Lab Internacional, S.A.B de C.V.
Company details
Genomma Lab was founded in 1996 and is headquartered in Mexico City, Mexico. Over-the-counter and generic drugs, along with personal care products, are produced and distributed by the company. These items address conditions such as acne, dandruff, warts, colitis, wrinkles, migraines, vaginal health issues, hemorrhoids, scars, and alopecia. Operations focus on the pharmaceutical and consumer health sectors.
- Annual Revenue$975.92 M (USD)-5.73as on Dec 31, 2025
- Net Profit$89.58 M (USD)8.1as on Dec 31, 2025
- EBITDA$230.35 M (USD)-3.04as on Dec 31, 2025
- Latest Funding Round$126M (USD), Debt – Conventional
May 2018
- Employee Count1,600
- Investments & AcquisitionsBufferin
& 1 more
Products & Services of Genomma Lab
Genomma Lab offers a comprehensive portfolio of products and services, including Medications and Personal Care Items.
Medications for various ailments such as pain and hydration are provided through innovative formulations.
Items for skin and hair care are supplied to support daily health maintenance.
Apps and channels of Genomma Lab
its YouTube channel Genomma has 10.2K subscribers and 30 videos.
Videos from Genomma Lab
The most watched videos on Genomma Lab's YouTube channel, Genomma (10.2K subscribers). Click a video to play it here.
More on Genomma.
Funding Insights of Genomma Lab
- Total Rounds 1
- Last Round Debt – Conventional — $126M
- First Round $126M
(May 2018)
All 1 funding rounds of Genomma Lab with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2018 | $126M | Debt – Conventional | – | – | – |
People of Genomma Lab
2 people are tracked at Genomma Lab (2 in leadership); the tracked headcount is 1,600.
| Name | Role | Group |
|---|---|---|
Rodrigo Herrera Aspra | Founder | Leadership |
Jorge Luis Brake Valderrama | CEO | Leadership |
Complete people profiles for Genomma Lab
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Genomma Lab
Genomma Lab is a publicly listed company on the BMV with ticker symbol LAB/B in Mexico, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date18 Jun 2008
- Listed onBMV: LABB
- Listed entityGenomma Lab Internacional SAB de CV Class B
- Exchange sectorHealth technology
- ISINMX01LA010006
- Share price13.31 MXN (+1.68% on the day) · 2026-10-13
- Market capitalisation13,310,000,420.00 MXN
- Price to earnings8.0
- EPS (diluted, trailing year)1.66 MXN
- Dividend yield6.01%
- Volume (last session)5,635,182
Financials of Genomma Lab
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 17.54B MXN | 1.61B MXN | 4.14B MXN |
| 2024 | 18.61B MXN | 1.49B MXN | 4.27B MXN |
| 2023 | 16.47B MXN | 1.03B MXN | 3.43B MXN |
| 2022 | 16.82B MXN | 1.39B MXN | 3.53B MXN |
| 2021 | 15.49B MXN | 1.31B MXN | 3.17B MXN |
Detailed financial statements for Genomma Lab
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genomma Lab
Genomma Lab has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Bufferin and Prestige Brands.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Hand sanitizer and aspirin products are manufactured by Bufferin. | bufferin.com | 1996 | Jun 2018 | •••• | ||
Over-the-counter healthcare products are provided for consumer health needs. | prestigebrands.com | Miami Beach, United States | 1996 | Feb 2012 | •••• |
Complete acquisition details for Genomma Lab
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Genomma Lab
5 dated milestones of Genomma Lab across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Genomma Lab is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Prestige Brands.
- Funding First funding round of $126.0M.
- Acquisition Acquires Bufferin.
Web traffic of Genomma Lab
The website of Genomma Lab (genommalab.com) receives about 38.6K visits a month.
- Monthly visits38.6K
▼ 30.1% vs previous month
Websites whose visitors overlap most with Genomma Lab. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
 mymanuel.wordpress.com | mymanuel.wordpress.com | 100% | – | ||
cicatricure.com.ar | cicatricure.com.ar | 77% | – | ||
facildedigerir.com | facildedigerir.com | 74% | – | ||
| prixz.com | 74% | 1.2M | #71,639 | View details | |
| asepxia.com | 73% | 5.8K | #3,354,396 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Genomma Lab
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genomma Lab
Complete news archive for Genomma Lab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genomma Lab
Genomma Lab was founded in 1996 and raised its 1st funding round 22 years after it was founded.
Genomma Lab is headquartered in Mexico City, Mexico.
Jorge Luis Brake Valderrama is the CEO of Genomma Lab, as recorded in our data.
Genomma Lab has 1,600 employees.
Annual revenue of Genomma Lab is $975.92M as on Dec 31, 2025.
Genomma Lab was founded in 1996 and is headquartered in Mexico City, Mexico. Over-the-counter and generic drugs, along with personal care products, are produced and distributed by the company. These items address conditions such as acne, dandruff, warts, colitis, wrinkles, migraines, vaginal health issues, hemorrhoids, scars, and alopecia. Operations focus on the pharmaceutical and consumer health sectors.
Genomma Lab offers Medications and Personal Care Items.
Yes, Genomma Lab is publicly traded on BMV under the ticker symbol LAB/B.
Genomma Lab has made 2 acquisitions, including Bufferin, and Prestige Brands.
Genomma Lab operates through Genomma Lab Internacional, S.A.B De C.V.